Frontiers in Cellular and Infection Microbiology,
Год журнала:
2024,
Номер
14
Опубликована: Апрель 10, 2024
Diabetes
mellitus
(DM)
refers
to
a
group
of
chronic
diseases
with
global
prevalence,
characterized
by
persistent
hyperglycemia
resulting
from
various
etiologies.
DM
can
harm
organ
systems
and
lead
acute
or
complications,
which
severely
endanger
human
well-being.
Traditional
treatment
mainly
involves
controlling
blood
sugar
levels
through
replacement
therapy
drugs
insulin;
however,
some
patients
still
find
satisfactory
curative
effect
difficult
achieve.
Extensive
research
has
demonstrated
close
correlation
between
enteric
dysbacteriosis
the
pathogenesis
types
DM,
paving
way
for
novel
therapeutic
approaches
targeting
gut
microbiota
manage
DM.
Fecal
transplantation
(FMT),
method
re-establishing
intestinal
microbiome
balance,
offers
new
possibilities
treating
diabetes.
This
article
provides
comprehensive
review
microbiota,
as
well
current
advancements
in
FMT
using
an
illustrative
example.
study
aims
offer
perspectives
establish
theoretical
foundation
clinical
diagnosis
management
Frontiers in Microbiology,
Год журнала:
2024,
Номер
14
Опубликована: Янв. 5, 2024
The
imbalance
of
microbial
composition
and
diversity
in
favor
pathogenic
microorganisms
combined
with
a
loss
beneficial
gut
microbiota
taxa
results
from
factors
such
as
age,
diet,
antimicrobial
administration
for
different
infections,
other
underlying
medical
conditions,
etc.
Probiotics
are
known
their
capacity
to
improve
health
by
stimulating
the
indigenous
microbiota,
enhancing
host
immunity
resistance
infection,
helping
digestion,
carrying
out
various
functions.
Concurrently,
metabolites
produced
these
microorganisms,
termed
postbiotics,
which
include
compounds
like
bacteriocins,
lactic
acid,
hydrogen
peroxide,
contribute
inhibiting
wide
range
bacteria.
This
review
presents
an
update
on
using
probiotics
managing
treating
human
diseases,
including
complications
that
may
emerge
during
or
after
COVID-19
infection.
Frontiers in Physiology,
Год журнала:
2024,
Номер
15
Опубликована: Июль 8, 2024
The
intestinal
wall
is
a
selectively
permeable
barrier
between
the
content
of
lumen
and
internal
environment
body.
Disturbances
permeability
can
potentially
lead
to
unwanted
activation
enteric
immune
system
due
excessive
contact
with
gut
microbiota
its
components,
development
endotoxemia,
when
level
bacterial
lipopolysaccharides
increases
in
blood,
causing
chronic
low-intensity
inflammation.
In
this
review,
following
aspects
are
covered:
structure
barrier;
influence
on
via
regulation
functioning
tight
junction
proteins,
synthesis/degradation
mucus
antioxidant
effects;
molecular
mechanisms
pro-inflammatory
response
caused
by
invasion
through
TLR4-induced
TIRAP/MyD88
TRAM/TRIF
signaling
cascades;
nutrition
permeability,
exercise
an
emphasis
exercise-induced
heat
stress
hypoxia.
Overall,
review
provides
some
insight
into
how
prevent
associated
inflammatory
processes
involved
many
if
not
most
pathologies.
Some
diets
physical
supposed
be
non-pharmacological
approaches
maintain
integrity
function
provide
efficient
operation.
However,
at
early
age,
increased
has
hormetic
effect
contributes
system.
Cells,
Год журнала:
2024,
Номер
13(6), С. 477 - 477
Опубликована: Март 8, 2024
The
gut
mucosal
epithelium
is
one
of
the
largest
organs
in
body
and
plays
a
critical
role
regulating
crosstalk
between
resident
microbiome
host.
To
this
effect,
tight
control
what
permitted
through
barrier
high
importance.
There
should
be
restricted
passage
harmful
microorganisms
antigens
while
at
same
time
allowing
absorption
nutrients
water.
An
increased
permeability,
or
“leaky
gut”,
has
been
associated
with
variety
diseases
ranging
from
infections,
metabolic
diseases,
inflammatory
autoimmune
to
neurological
conditions.
Several
factors
can
affect
including
cytokines,
dietary
components,
microbiome.
Here,
we
discuss
how
impacts
permeability
epithelial
harnessed
for
therapeutic
purposes.
International Journal of Molecular Sciences,
Год журнала:
2023,
Номер
24(22), С. 16502 - 16502
Опубликована: Ноя. 19, 2023
Cirrhosis
is
the
end
result
of
liver
fibrosis
in
chronic
diseases.
Studying
mechanisms
its
development
and
developing
measures
to
slow
down
regress
it
based
on
this
knowledge
seem
be
important
tasks
for
medicine.
Currently,
disorders
gut–liver
axis
have
great
importance
pathogenesis
cirrhosis.
However,
gut
dysbiosis,
which
manifests
as
increased
proportions
microbiota
Bacilli
Proteobacteria
that
are
capable
bacterial
translocation
a
decreased
proportion
Clostridia
strengthen
intestinal
barrier,
occurs
even
at
pre-cirrhotic
stage
disease.
This
leads
translocation,
process
by
those
microbes
enter
blood
portal
vein
then
tissue,
where
they
activate
Kupffer
cells
through
Toll-like
receptor
4.
In
response,
produce
profibrogenic
cytokines,
hepatic
stellate
cells,
stimulating
their
transformation
into
myofibroblasts
collagen
other
elements
extracellular
matrix.
Blocking
with
antibiotics,
probiotics,
synbiotics,
methods
could
progression
fibrosis.
was
shown
number
animal
models
but
requires
further
verification
long-term
randomized
controlled
trials
humans.
Foods,
Год журнала:
2024,
Номер
13(23), С. 3886 - 3886
Опубликована: Дек. 1, 2024
Foodborne
pathogens
are
microorganisms
that
cause
illness
through
contamination,
presenting
significant
risks
to
public
health
and
food
safety.
This
review
explores
the
metabolites
produced
by
these
pathogens,
including
toxins
secondary
metabolites,
their
implications
for
human
health,
particularly
concerning
cancer
risk.
We
examine
various
such
as
Salmonella
sp.,
Campylobacter
Escherichia
coli,
Listeria
monocytogenes,
detailing
specific
of
concern
carcinogenic
mechanisms.
study
discusses
analytical
techniques
detecting
chromatography,
spectrometry,
immunoassays,
along
with
challenges
associated
detection.
covers
effective
control
strategies,
processing
techniques,
sanitation
practices,
regulatory
measures,
emerging
technologies
in
pathogen
control.
manuscript
considers
broader
highlighting
importance
robust
policies,
awareness,
education.
identifies
research
gaps
innovative
approaches,
recommending
advancements
detection
methods,
preventive
policy
improvements
better
manage
foodborne
metabolites.
Nutrients,
Год журнала:
2024,
Номер
16(16), С. 2657 - 2657
Опубликована: Авг. 11, 2024
Irritable
bowel
syndrome
(IBS)
is
a
prevalent
functional
gastrointestinal
disorder
characterized
by
abdominal
pain,
bloating,
diarrhea,
and
constipation.
Recent
studies
have
underscored
the
significant
role
of
gut
microbiota
in
pathogenesis
IBS.
Physical
exercise,
as
non-pharmacological
intervention,
has
been
proposed
to
alleviate
IBS
symptoms
modulating
microbiota.
Aerobic
such
running,
swimming,
cycling,
shown
enhance
diversity
abundance
beneficial
bacteria,
including
Lactobacillus
Bifidobacterium.
These
bacteria
produce
short-chain
fatty
acids
that
possess
anti-inflammatory
properties
support
barrier
integrity.
Studies
involving
patients
participating
structured
aerobic
exercise
programs
reported
improvements
their
microbiota's
composition
diversity,
alongside
an
alleviation
like
pain
bloating.
Additionally,
positively
influences
mental
health
reducing
stress
improving
mood,
which
can
further
relieve
via
gut-brain
axis.
Long-term
interventions
provide
sustained
benefits,
maintaining
stability,
supporting
immune
functions,
systemic
inflammation.
However,
must
be
tailored
individual
needs
avoid
exacerbating
symptoms.
Personalized
plans
starting
with
low-to-moderate
intensity
gradually
increasing
maximize
benefits
minimize
risks.
This
review
examines
impact
various
types
intensities
physical
on
patients,
highlighting
need
for
explore
optimal
protocols.
Future
research
should
include
larger
sample
sizes,
longer
follow-up
periods,
examine
synergistic
effects
other
lifestyle
modifications.
Integrating
into
comprehensive
management
symptom
control
improve
patients'
quality
life.
Antioxidants,
Год журнала:
2025,
Номер
14(1), С. 56 - 56
Опубликована: Янв. 6, 2025
Metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD)
is
a
prevalent
chronic
condition
marked
by
excessive
lipid
accumulation
in
hepatic
tissue.
This
disorder
can
lead
to
range
of
pathological
outcomes,
including
metabolic
steatohepatitis
(MASH)
and
cirrhosis.
Despite
extensive
research,
the
molecular
mechanisms
driving
MASLD
initiation
progression
remain
incompletely
understood.
Oxidative
stress
peroxidation
are
pivotal
"multiple
parallel
hit
model",
contributing
cell
death
tissue
damage.
Gut
microbiota
plays
substantial
role
modulating
oxidative
through
multiple
pathways:
impairing
intestinal
barrier,
which
results
bacterial
translocation
inflammation;
modifying
bile
acid
structure,
impacts
signaling
cascades
involved
lipidic
metabolism;
influencing
hepatocytes'
ferroptosis,
form
programmed
death;
regulating
trimethylamine
N-oxide
(TMAO)
activating
platelet
function,
both
recently
identified
as
pathogenetic
factors
MASH
progression.
Moreover,
various
exogenous
impact
gut
its
involvement
MASLD-related
stress,
such
air
pollution,
physical
activity,
cigarette
smoke,
alcohol,
dietary
patterns.
manuscript
aims
provide
state-of-the-art
overview
focused
on
intricate
interplay
between
microbiota,
peroxidation,
pathogenesis,
offering
insights
into
potential
strategies
prevent
associated
complications.
Abstract
The
microbiota-
gut-brain
interaction
is
a
fundamental
aspect
of
the
synergy
between
microbiota
and
host
in
accessing
signaling
pathways
to
modulate
brain
function
behavior.
bilateral
cross-communication,
which
might
be
direct
or
indirect,
within
line
axis
becoming
promising
therapeutic
target
for
central
nervous
system
(CNS)
disorders,
including
Alzheimer’s
disease
(AD).
Dysbiosis
creates
an
imbalance
abundance
pro-inflammatory
anti-inflammatory
species,
species’
availability
may
vary
based
on
type
neurodegenerative
diseases.
final
outcome
(i.e.,
dysbiosis)
follows
similar
approach,
leading
shift
towards
state
gut,
increased
gut
permeability,
triggered
peripheral
inflammatory
response
consequently
occurs.
To
fully
exploit
impact
interventions
AD,
scientific
investigations
help
understand
complex
neuroinflammatory
mechanisms
investigating
potential
modulating
future
therapies.